Literature DB >> 29964084

Protective effects of hydroxytyrosol against α-synuclein toxicity on PC12 cells and fibril formation.

Ruth Hornedo-Ortega1, Ana B Cerezo1, Ana M Troncoso1, M Carmen Garcia-Parrilla2.   

Abstract

There is a considerable consensus that the increased production and/or aggregation of α-synuclein (αsyn) plays a central role in the pathogenesis of Parkinson's disease (PD). Therefore, a method of identifying molecules that block αsyn aggregation and prevent the loss of dopaminergic neurons is urgently needed in order to treat or slow the progression of PD. Hydroxytyrosol (HT), a well-known bioactive food compound present in olive oil, olives and wine, possesses demonstrated antioxidant and anti-inflammatory properties that can cross the Blood Brain Barrier (BBB). In the present work, the role of HT, tyrosol (TYR) and other tyrosine metabolites (hydroxyphenyl acetic acid (HPAA)) against αsyn aggregation, destabilisation and toxicity was evaluated through the use of different in vitro tests (Thioflavin T (ThT), Transmission Electronic Microscopy (TEM), electrophoresis and MTT assay). Results show that HT presents a strong inhibitory effect preventing αsyn aggregation and exercising a destabilising effect by disaggregating αsyn fibrils. Moreover, HT is able to counteract αsyn-induced toxicity. This is the first time that the effect of HT against αsyn toxicity and aggregation is evaluated. Thus, HT can be considered a promising compound for further approaches to tackling PD.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29964084     DOI: 10.1016/j.fct.2018.06.059

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  8 in total

1.  Evidences of hydroxytyrosol as an anti-inflammatory agent in Parkinson's disease: insights into the mechanisms of action.

Authors:  Ruth Hornedo-Ortega; Ana María Espinosa-Oliva
Journal:  Neural Regen Res       Date:  2021-05       Impact factor: 5.135

2.  Hydroxytyrosol Inhibits Protein Oligomerization and Amyloid Aggregation in Human Insulin.

Authors:  Ivana Sirangelo; Margherita Borriello; Silvia Vilasi; Clara Iannuzzi
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

3.  Anti-VEGF Effect of Bioactive Indolic Compounds and Hydroxytyrosol Metabolites.

Authors:  Marta Gallardo-Fernández; Ana B Cerezo; Ruth Hornedo-Ortega; Ana M Troncoso; M Carmen Garcia-Parrilla
Journal:  Foods       Date:  2022-02-11

Review 4.  Hydroxytyrosol in Foods: Analysis, Food Sources, EU Dietary Intake, and Potential Uses.

Authors:  Marta Gallardo-Fernández; Marina Gonzalez-Ramirez; Ana B Cerezo; Ana M Troncoso; M Carmen Garcia-Parrilla
Journal:  Foods       Date:  2022-08-06

5.  Micellar Nanocarriers of Hydroxytyrosol Are Protective against Parkinson's Related Oxidative Stress in an In Vitro hCMEC/D3-SH-SY5Y Co-Culture System.

Authors:  Leah Mursaleen; Brendon Noble; Satyanarayana Somavarapu; Mohammed Gulrez Zariwala
Journal:  Antioxidants (Basel)       Date:  2021-05-31

Review 6.  Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein.

Authors:  Ming-Ming Xu; Philip Ryan; Santosh Rudrawar; Ronald J Quinn; Hai-Yan Zhang; George D Mellick
Journal:  Acta Pharmacol Sin       Date:  2019-10-04       Impact factor: 6.150

7.  Hydroxytyrosol Decreases LPS- and α-Synuclein-Induced Microglial Activation In Vitro.

Authors:  Marta Gallardo-Fernández; Ruth Hornedo-Ortega; Isabel M Alonso-Bellido; José A Rodríguez-Gómez; Ana M Troncoso; M Carmen García-Parrilla; José L Venero; Ana M Espinosa-Oliva; Rocío M de Pablos
Journal:  Antioxidants (Basel)       Date:  2019-12-31

Review 8.  Natural and Synthetic Derivatives of Hydroxycinnamic Acid Modulating the Pathological Transformation of Amyloidogenic Proteins.

Authors:  Vladimir I Muronetz; Kseniya Barinova; Sofia Kudryavtseva; Maria Medvedeva; Aleksandra Melnikova; Irina Sevostyanova; Pavel Semenyuk; Yulia Stroylova; Matej Sova
Journal:  Molecules       Date:  2020-10-12       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.